Sponge implant in Swiss mice as a model for studying loxoscelism

Toxicon

Volumn 59, Issue 7-8, 2012, Pages 672-679

  Pereira, Núbia Braga ^a,d   Campos, Paula Peixoto ^a,d   De Jesus Oviedo Socarrás, Teresa ^f   Pimenta, Thaiane Salgado ^a,d   Parreiras, Patrícia Martins ^e   Silva, Soraia Silvéria ^a,d   Kalapothakis, Evanguedes ^c,d   Andrade, Silvia Passos ^b,d   Moro, Luciana ^a,d  

^a Departamento de Patologia Geral   (Brazil)

^b Departamento de Fisiologia e Biofísica   (Brazil)

^c Departamento de Biologia Geral   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f UNIVERSIDAD DE CÓRDOBA   (Colombia)

Author keywords

Loxosceles; Loxoscelism; Sponge implants

Indexed keywords

CYTOKINE; KETAMINE; MYELOPEROXIDASE; N ACETYL BETA GLUCOSAMINIDASE; POLYETHERURETHAN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CONTROLLED STUDY; EDEMA; ENVENOMATION; ENZYME ACTIVITY; GRANULATION TISSUE; HYPEREMIA; IMPLANT; LEUKOCYTE ACTIVATION; LOXOSCELES SIMILIS; LOXOSCELISM; MACROPHAGE ACTIVATION; MALE; MOLECULAR MECHANICS; MORPHOMETRICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPIDER; SPIDER BITE; SPONGE (PORIFERA); VASODILATATION;

ANIMALS; ARACHNIDISM; EDEMA; GRANULATION TISSUE; HEMOGLOBINS; HEMORRHAGE; HEXOSAMINIDASES; INFLAMMATION; MALE; MICE; MODELS, ANIMAL; NEUTROPHILS; PEROXIDASE; PHOSPHORIC DIESTER HYDROLASES; SPIDER VENOMS; SPIDERS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASODILATION;

ANIMALIA; ARANEAE; LOXOSCELES; LOXOSCELES SIMILIS; MURINAE; MUS; ORYCTOLAGUS CUNICULUS;

EID: 84859128183     PISSN: 00410101     EISSN: 18793150     Source Type: Journal    
DOI: 10.1016/j.toxicon.2012.02.005     Document Type: Article

References (37)

1. Abdulkader R.C.R.M., Barbaro K.C., Barros E.J.G., Burdmann E.A. Nephrotoxicity of insect and spider in Latin America. Sem. Nephrol. 2008, 28:373-382.
2. Andrade S.P., Ferreira M.A. The sponge implant model of angiogenesis. Methods Mol. Biol. 2009, 467:295-304.
3. Ballou L.R., Laulederkind S.J.F., Rosloniec E.F., Raghow R. Ceramide signaling and the immune response. Biochem. Biophys. Acta 1996, 1301:273-287.
4. Barbaro K.C., Eickstedt V.R.D., Mota I. Adjuvant effect of Loxosceles gaucho (South American Brown spider) venon. Toxicon 1994, 32:687-693.
5. Barbaro K.C., Knysak I., Martins R., Hogan C., Winkel K. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas. Toxicon 2005, 45(4):489-499.
6. Barbaro K.C., Lira M.S., Araújo C.A., Pareja-Santos A., Távora B.C., Prezotto-Neto J.P., Kimura L.F., Lima C., Lopes-Ferreira M., Santoro M.L. Inflammatory mediators generated at the site of inoculation of Loxosceles gaucho spider venom. Toxicon 2010, 56:972-979.
7. Campos P.P., Bakhle Y.S., Andrade S.P. Mechanisms of wound healing responses in lupus-prone New Zealand White mouse strain. Wound Repair Regen. 2008, 16(3):416-424.
8. Campos P.P., Vasconcelos A.C., Ferreira M.A., Andrade S.P. Alterations in the dynamics of inflammation, proliferation and apoptosis in subcutaneous implants of lupus-prone mice. Histol. Histopathol. 2011, 26(4):433-442.
9. Da Silva P.H., Da Silveira R.B., Appel M.H., Mangili O.C., Gremski W., Veiga S.S. Brown spiders and loxoscelism. Toxicon 2004, 44:693-709.
10. Da Silveira R.B., Pigozzo R.B., Chaim O.M., Appel M.H., Silva D.T., Dreyfuss J.L., Toma L., Dietrich C.P., Nader H.B., Veiga S.S., Gremski W. Two novel dermonecrotic toxins LiRecDT4 and LiRecDT5 from brown spider (Loxosceles intermedia) venom: from cloning to functional characterization. Biochimie 2007, 89(3):289-300.
11. Desai A., Lankford H.A., Warren J.S. Loxosceles deserta spider venom induces the expression of vascular endothelial growth factor (VEGF) in keratinocytes. Inflammation 2000, 24:1-9.
12. Domingos M.O., Tynanb W., Barbaro K.C., Pennyd J., Lewis D.J.M., New R.R.C. Effect of Loxosceles gaucho venom on cell morphology and behaviour in vitro in the presence and absence of sphingomyelin. Toxicon 2003, 42:471-479.
13. Drabkin D.L., Austin J.H. Spectrophotometric constants common hemoglobin derivatives in human, dog, and rabbit blood. J. Biol. Chem. 1932, 98:719-733.
14. Felicori L., Araujo S.C., de Avila R.A., Sanchez E.F., Granier C., Kalapothakis E., Chavez-Olortegui C. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider. Toxicon 2006, 48(5):509-519.
15. Futrell J.M. Loxoscelism. Am. J. Med. Sci. 1992, 304:261-267.
16. Gajardo-Tobar R.R. Minha experiência sobre loxoscelismo. Mem. Inst. Butantan 1966, 33:689-698.
17. He X., Chen F., Gatt S., Shuchman E.H. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease. Anal. Biochem. 2001, 293:204-211.
18. Hogan C.J., Barbaro K.C., Winkel K. Loxoscelism: old obstacles, new directions. Ann. Emerg. Med. 2004, 44:608-624.
19. Kalapothakis E., Chatzaki M., Gonçalves-Dornelas H., Castro C.S., Silvestre F.G., Laborne F.V., De Moura J.F., Veiga S.S., Chávez- Olórtegui C., Granier C., Barbaro K.C. The Loxtox protein family in Loxosceles intermedia (Mello-Leitão) venom. Toxicon 2007, 50:938-946.
20. Málaque C.M.S., Castro-Valencia J.E., Cardoso J.L.C., França F.O.S., Bárbaro K.C., Fan H.W. Clinical and epidemiological features of definitive and presumed loxoscelism in São Paulo, Brazil. Rev. Inst. Med. Trop. São Paulo 2002, 44(3):139-143.
21. Málaque C.M.S., Ori M., Santos S.A., Andrade D.R. Production of TNF-a by primary cultures of human keratinocytes challenged with Loxosceles gaucho venom. Rev. Inst. Med. Trop. São Paulo 1999, 41:179-182.
22. Marques S.M., Campos P.P., Castro P.R., Cardoso C.C., Ferreira M.A., Andrade S.P. Genetic background determines mouse strain differences in inflammatory angiogenesis. Microvasc. Res. 2011, Aug 31 (Epub ahead of print).
23. Ospedal K.Z., Appel M.H., Neto J.F., Mangili O.C., Veiga S.S., Gremski W. Histopathological findings in rabbits after experimental acute exposure to the Loxosceles intermedia (Brown spider) venom. Int. J. Exp. Pathol. 2002, 83:287-294.
24. Parrilha G.L., Vieira R.P., Campos P.P., Silva G.D., Duarte L.P., Andrade S.P., Beraldo H. Coordination of lapachol to bismuth(III) improves its anti-inflammatory and anti-angiogenic activities. Biometals 2011, Aug 6 (Epub ahead of print).
25. Patel K.D., Modur V., Zimmermann G.A., Prescott S.M., Mcintry T.M. The necrotic venom of the brown recluse spider induces dysregulated endothelial cell-dependent neutrophil activation. Differential induction of GM-CSF, IL-8 and Eselectin expression. J. Clin. Invest. 1994, 94:631-642.
26. Pereira N.B., Kalapothakis E., Campos L.P., Vasconcelos A.C., Moro L. Apoptose na patogenia do Loxoscelismo cutâneo experimental em coelhos: abordagens morfológica e imunoistoquímica. Rev. Bras. Toxicol. 2010, 23(1):136.
27. Petricevich V.L. Cytokine and nitric oxide production following severe envenomation. Curr. Drug. Targets Inflamm. Allergy 2004, 3:325-332.
28. Robinson C.J., Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 2001, 114:853-865.
29. Schenone H., Saavedra T., Rojas A., Vilarroel F. Loxoscelismo en Chile. Estudios epidemiológicos, clínicos y experimentales. Rev. Inst. Med. Trop. São Paulo 1989, 31:403-415.
30. Silvestre F.G., Castro C.S., De Moura J.F., Giusta M.S., De Maria M., álvares é.S.S., Lobato F.C.F., Assis R.A., Gonçalves L.A., Gubert I.C., Chávez-Olórtegui C., Kalapothakis E. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae). Toxicon, England 2005, 46:927-936.
31. Smith W.C., Micks W.D. The role of polimorphonuclear leukocytes in the lesion caused by the venom of the brown spider (Loxosceles reclusa). Lab. Invest. 1970, 22:90-93.
32. Souza A.L., Málaque C.M., Sztajnbok J., Romano C.C., Duarte A.J., Seguro A.C. Loxosceles venom-induced cytokine activation, hemolysis, and acute kidney injury. Toxicon 2008, 51:151-156.
33. Sunderkötter C., Seeliger S., Schönlau F., et al. Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp. Dermatol. 2001, 10:391-404.
34. Swanson D.L., Vetter R.S. Loxoscelism. Clin. Dermatol. 2006, 24(3):213-221.
35. Veiga S.S., Feitosa L., Santos V.L.P., Souza G.A., Ribeiro A.S., Porcionatto M.A., Nader H.B., Dietrich C.P., Brentani R.R., Gremski W. Effect of brown spider venom on basement membrane structures. Histochem. J. 2000, 32:397-408.
36. Veiga S.S., Zanetti V.C., Franco C.R.C., Trindade E.S., Porcionatto M.A., Mangili O.C., Gremski W., Nader H.B., Dietrich C.P. In vivo and in vitro cytotoxicity of brown spider venom for blood vessel endothelial cells. Thromb. Res. 2001, 102:229-237.
37. Vieira L.B., Rodrigues J.A., Leite V.H., Andrade S.P. Angiogenic activity of PAF and inhibition of blood flow by Bothrops jararaca venom in a mouse sponge model. EXS 1992, 61:302-307.